Healthcare - Biotechnology - NASDAQ - US
$ 0.6
-14.3 %
$ 877 M
Market Cap
None
P/E
INCOME STATEMENT
54 M
REVENUE
-102 M
OPERATING INCOME
-97 M
NET INCOME
EFFICIENCY
Earnings Waterfall
immatics biotechnologies GmbH
| Revenue | 54 M |
| Cost Of Revenue | 119 M |
| Gross Profit | -64.7 M |
| Operating Expenses | 156 M |
| Operating Income | -102 M |
| Other Expenses | -4.73 M |
| Net Income | -97 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 54.0 | 172.8 | 34.8 | 31.3 | 18.4 | 3.8 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 118.7 | 106.8 | 87.6 | 67.1 | 40.1 | 34.0 |
| Gross Profit | (64.7) | 66.1 | (52.8) | (35.8) | (21.6) | (30.2) |
| OPERATING INCOME | ||||||
| Operating Expenses | 155.7 | 142.9 | 121.0 | 101.0 | 51.5 | 38.2 |
| Selling, General and Administrative Expenses | 38.2 | 36.1 | 33.8 | 34.2 | 11.8 | 7.7 |
| Research and Development Expenses | 118.7 | 106.8 | 87.6 | 67.1 | 40.1 | 34.0 |
| Operating Income | (101.7) | 30.0 | (86.3) | (69.7) | (33.0) | (34.4) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0.8 | 8.3 | 1.7 | 0.3 | 0.2 | 16 K |
| Total Other Income | 4.7 | 12.1 | (7.0) | (142.1) | 0.5 | 2.1 |
| Pre-Tax Income | (97.0) | 42.0 | (93.3) | (229.6) | (32.5) | (32.4) |
| NET INCOME | ||||||
| Tax Provision | 0 | 4.6 | 1.7 | (0.3) | (0.7) | (3.0) |
| Net Income | (97.0) | 37.5 | (95.1) | (229.3) | (31.7) | (31.4) |
| EPS | 1.2 | 0.55 | 1.51 | 4.78 | 0.5 | 0.5 |